Pharmya

  • Home
  • About us
  • Services
    • Pharmacovigilance Systems
    • Operational Pharmacovigilance Activities
    • EU QPPV & Local QPPV services
    • Pharmacovigilance Audits and Training
  • News
  • Careers
  • Contact us
  • English
  • Français
  • Español
You are here: Pharmya > Articles by: Ryan McArthur
Standing Scientific Committee on Surveillance and Pharmacovigilance – Restricted Expertise Session of 15 November 2022 minutes
2023 March Mar 20

Standing Scientific Committee on Surveillance and Pharmacovigilance – Restricted Expertise Session of 15 November 2022 minutes

Read more
Guideline on computerised systems and electronic data in clinical trials
2023 March Mar 17

Guideline on computerised systems and electronic data in clinical trials

Read more
Welcome to the team!
2023 March Mar 09

Welcome to the team!

The Pharmya team is growing! A big welcome to Angélique, our new team assistant!

Read more
Questions and answers – Clinical Trials Information System (CTIS) and Clinical Trials Regulation (CTR)
2023 March Mar 03

Questions and answers – Clinical Trials Information System (CTIS) and Clinical Trials Regulation (CTR)

Read more
List of medicines under additional monitoring
2023 February Feb 27

List of medicines under additional monitoring

https://www.ema.europa.eu/en/human-regulatory/post-authorisation/pharmacovigilance/medicines-under-additional-monitoring/list-medicines-under-additional-monitoring

Read more
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20 – 23 February 2023
2023 February Feb 24

Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 20 – 23 February 2023

https://www.ema.europa.eu/en/news/meeting-highlights-committee-medicinal-products-human-use-chmp-20-23-february-2023

Read more
EMA: Minutes of PRAC meeting on 26 – 29 September 2022
2023 February Feb 20

EMA: Minutes of PRAC meeting on 26 – 29 September 2022

Read more
Human medicines: highlights of 2022
2023 February Feb 17

Human medicines: highlights of 2022

https://www.ema.europa.eu/en/news/human-medicines-highlights-2022

Read more
EMA list of frequently asked questions
2023 February Feb 13

EMA list of frequently asked questions

Read more
Welcome to the team!
2023 February Feb 09

Welcome to the team!

The Pharmya Team is happy to welcome Manel, our new PV Expert trainee!

Read more
  • « Previous
  • Next »

Pharmya – Pharmacovigilance

PHARMYA is a French based company, dedicated to providing Pharmacovigilance services. Its mission is to support the pharmaceutical industry, biotechnology companies, research centers and their service providers in their efforts to comply with international Pharmacovigilance regulations.

In partnership with the region

Contact

  • PHARMYA
  • 315 Av. Saint Sauveur du Pin
  • 34980 Saint Clément de Rivière (Montpellier), France
  • Phone: +33 411 93 21 10
  • Email: info@pharmya.com
  • Website: www.pharmya.com

News

  • Pharmacovigilance Risk Assessment Committee (PRAC) – Minutes of PRAC meeting on 13 – 16 January 2025
  • CTIS newsflash – 25 March 2025
  • 2024 Annual Report on EudraVigilance for the European Parliament, the Council and the Commission
Copyright © 2018 - Pharmya - Legal terms - Quality Policy